- Home
- THFF vs HUMA Comparison
THFF vs HUMA Comparison
Compare THFF & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THFF
- HUMA
- Stock Information
- Founded
- THFF 1984
- HUMA 2004
- Country
- THFF United States
- HUMA United States
- Employees
- THFF N/A
- HUMA N/A
- Industry
- THFF Major Banks
- HUMA Biotechnology: Pharmaceutical Preparations
- Sector
- THFF Finance
- HUMA Health Care
- Exchange
- THFF Nasdaq
- HUMA Nasdaq
- Market Cap
- THFF 686.6M
- HUMA 250.2M
- IPO Year
- THFF N/A
- HUMA N/A
- Fundamental
- Price
- THFF $57.96
- HUMA $1.53
- Analyst Decision
- THFF Buy
- HUMA Strong Buy
- Analyst Count
- THFF 3
- HUMA 8
- Target Price
- THFF $59.50
- HUMA $10.88
- AVG Volume (30 Days)
- THFF 46.5K
- HUMA 2.9M
- Earning Date
- THFF 10-21-2025
- HUMA 11-07-2025
- Dividend Yield
- THFF 3.49%
- HUMA N/A
- EPS Growth
- THFF 21.43
- HUMA N/A
- EPS
- THFF 5.24
- HUMA N/A
- Revenue
- THFF $230,446,000.00
- HUMA $818,000.00
- Revenue This Year
- THFF $30.73
- HUMA N/A
- Revenue Next Year
- THFF $2.82
- HUMA $1,619.38
- P/E Ratio
- THFF $11.16
- HUMA N/A
- Revenue Growth
- THFF 19.59
- HUMA N/A
- 52 Week Low
- THFF $40.57
- HUMA $1.15
- 52 Week High
- THFF $60.77
- HUMA $6.77
- Technical
- Relative Strength Index (RSI)
- THFF 52.96
- HUMA 42.17
- Support Level
- THFF $56.84
- HUMA $1.45
- Resistance Level
- THFF $59.07
- HUMA $1.53
- Average True Range (ATR)
- THFF 1.10
- HUMA 0.09
- MACD
- THFF -0.27
- HUMA 0.04
- Stochastic Oscillator
- THFF 28.50
- HUMA 51.72
About THFF First Financial Corporation Indiana
First Financial Corp operates as a financial holding company, which is engaged in the provision of financial services in the United States. The company offers a wide variety of financial services including commercial, mortgage, and consumer lending, lease financing, trust account services, depositor services and insurance services, through its subsidiaries. Its primary source of revenue is derived from loans to customers and investment activities.
About HUMA Humacyte Inc.
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.